1. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas. (19th July 2013) Authors: Sawant, SS; Vaidya, MM; Chaukar, DA; Alam, H; Dmello, C; Gangadaran, P; Kannan, S; Kane, S; Dange, PP; Dey, N; Ranganathan, K; D'Cruz, AK Journal: Oral diseases Issue: Volume 20:Number 5(2014:Jul.) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas. (19th July 2013) Authors: Sawant, SS; Vaidya, MM; Chaukar, DA; Alam, H; Dmello, C; Gangadaran, P; Kannan, S; Kane, S; Dange, PP; Dey, N; Ranganathan, K; D'Cruz, AK Journal: Oral diseases Issue: Volume 20:Number 5(2014:Jul.) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS08.6.A Novel role of ARF4-mediated retrograde trafficking as a driver of chemoresistance in GBM. (5th September 2022) Authors: Budhiraja, S; Baisiwala, S; Perrault, E; Cho, S; Dara, G; Nandoliya, K; Zolp, A; Chen, L; Dmello, C; Park, C; Sonabend, A; Ahmed, A Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗